These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35191689)

  • 21. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
    Baumketner A; Krone MG; Shea JE
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
    Chong SH; Yim J; Ham S
    Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
    Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
    Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.
    Pillot T; Goethals M; Vanloo B; Talussot C; Brasseur R; Vandekerckhove J; Rosseneu M; Lins L
    J Biol Chem; 1996 Nov; 271(46):28757-65. PubMed ID: 8910517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.
    Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P
    J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
    Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
    ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Hexamer of a Peptide Derived from Aβ
    Kreutzer AG; Spencer RK; McKnelly KJ; Yoo S; Hamza IL; Salveson PJ; Nowick JS
    Biochemistry; 2017 Nov; 56(45):6061-6071. PubMed ID: 29028351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
    Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
    ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two-step strategy for structure-activity relationship studies of N-methylated aβ42 C-terminal fragments as aβ42 toxicity inhibitors.
    Li H; Zemel R; Lopes DH; Monien BH; Bitan G
    ChemMedChem; 2012 Mar; 7(3):515-22. PubMed ID: 22307963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.
    Walsh DM; Hartley DM; Condron MM; Selkoe DJ; Teplow DB
    Biochem J; 2001 May; 355(Pt 3):869-77. PubMed ID: 11311152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
    Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
    Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection.
    De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D
    FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease.
    Van Vickle GD; Esh CL; Kokjohn TA; Patton RL; Kalback WM; Luehrs DC; Beach TG; Newel AJ; Lopera F; Ghetti B; Vidal R; Castaño EM; Roher AE
    Mol Med; 2008; 14(3-4):184-94. PubMed ID: 18317569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Affinity Binding of Monomeric but Not Oligomeric Amyloid-β to Ganglioside GM1 Containing Nanodiscs.
    Thomaier M; Gremer L; Dammers C; Fabig J; Neudecker P; Willbold D
    Biochemistry; 2016 Dec; 55(48):6662-6672. PubMed ID: 27933798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A beta-amyloid peptide variant related with familial Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis is poorly eliminated by cathepsin D.
    Hamazaki H
    FEBS Lett; 1996 Nov; 397(2-3):313-5. PubMed ID: 8955370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.